Skip to main content
Premium Trial:

Request an Annual Quote

TGEN to Provide DNA Analysis Services Using Affymetrix Technology

NEW YORK, Feb. 11 (GenomeWeb News) - Affymetrix and the Translational Genomics Research Institute of Phoenix, Ariz., today announced a non-exclusive agreement where TGEN genotyping services to its collaborators and NIH-funded core facility programs using Affymetrix's DNA analysis technology.

TGen currently runs gene expression core facility programs on the Affymetrix platform for The National Institutes of Mental Health and the National Institutes of Neurological Disease and Stroke. As part of this agreement, these programs have been expanded to run the Affymetrix DNA analysis technologies. Affymetrix and TGen also agreed to a framework under which they will collaborate on future projects.

Financial details of the agreement were not disclosed.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.